Dr. Castano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
173 Fort Washington Ave
New York, NY 10032
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 2013 - 2017
- Columbia University Mailman School of Public HealthMS, Statistics, 2014 - 2016
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
- Columbia University Vagelos College of Physicians and Surgeons2010 - 2013
- University of Michigan Medical SchoolClass of 2010
- Princeton UniversityBA, Molecular Biology, Spanish Literature, 2001 - 2005
Certifications & Licensure
- NY State Medical License 2012 - 2026
Publications & Presentations
PubMed
- 446 citationsUnveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.Adam Castano, David L. Narotsky, Nadira Hamid, Omar K. Khalique, Rachelle Morgenstern
European Heart Journal. 2017-10-07 - 1150 citationsNonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.Julian D. Gillmore, Mathew S. Maurer, Rodney H. Falk, Giampaolo Merlini, Thibaud Damy
Circulation. 2016-06-14 - 76 citationsSerial scanning with technetium pyrophosphate ( 99m Tc-PYP) in advanced ATTR cardiac amyloidosis.Adam Castano, Albert DeLuca, Richard Weinberg, Ted Pozniakoff, William S. Blaner
Journal of Nuclear Cardiology. 2016-12-01
Press Mentions
- Drug Reduces Hospitalization, Death from Progressive Form of Heart FailureAugust 27th, 2018
- Resurrecting Tc 99m PYP: As Cardiac Amyloidosis Therapies Emerge, an Old Test Gains a New PurposeJuly 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: